- Home
- TSHA vs WGO Comparison
TSHA vs WGO Comparison
Compare TSHA & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- WGO
- Stock Information
- Founded
- TSHA 2019
- WGO 1958
- Country
- TSHA United States
- WGO United States
- Employees
- TSHA N/A
- WGO N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- WGO Homebuilding
- Sector
- TSHA Health Care
- WGO Industrials
- Exchange
- TSHA Nasdaq
- WGO Nasdaq
- Market Cap
- TSHA 1.4B
- WGO 1.1B
- IPO Year
- TSHA 2020
- WGO N/A
- Fundamental
- Price
- TSHA $3.84
- WGO $36.45
- Analyst Decision
- TSHA Strong Buy
- WGO Buy
- Analyst Count
- TSHA 9
- WGO 12
- Target Price
- TSHA $10.22
- WGO $39.40
- AVG Volume (30 Days)
- TSHA 4.1M
- WGO 756.1K
- Earning Date
- TSHA 11-04-2025
- WGO 12-19-2025
- Dividend Yield
- TSHA N/A
- WGO 3.83%
- EPS Growth
- TSHA N/A
- WGO 106.82
- EPS
- TSHA N/A
- WGO 0.91
- Revenue
- TSHA $6,310,000.00
- WGO $2,798,200,000.00
- Revenue This Year
- TSHA N/A
- WGO $3.24
- Revenue Next Year
- TSHA N/A
- WGO $5.57
- P/E Ratio
- TSHA N/A
- WGO $40.21
- Revenue Growth
- TSHA N/A
- WGO N/A
- 52 Week Low
- TSHA $1.05
- WGO $28.00
- 52 Week High
- TSHA $5.51
- WGO $65.65
- Technical
- Relative Strength Index (RSI)
- TSHA 37.78
- WGO 52.87
- Support Level
- TSHA $3.89
- WGO $35.73
- Resistance Level
- TSHA $4.55
- WGO $37.73
- Average True Range (ATR)
- TSHA 0.39
- WGO 1.72
- MACD
- TSHA -0.19
- WGO -0.11
- Stochastic Oscillator
- TSHA 8.99
- WGO 52.97
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About WGO Winnebago Industries Inc.
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.